Bristol-Myers Squibb Company (BMY)

55.43
0.52 0.93
NYSE : Health Care
Prev Close 55.95
Open 55.96
Day Low/High 55.30 / 56.00
52 Wk Low/High 46.01 / 77.12
Volume 6.00M
Avg Volume 13.52M
Exchange NYSE
Shares Outstanding 1.65B
Market Cap 92.59B
EPS 2.70
P/E Ratio 21.21
Div & Yield 1.56 (2.80%)

Latest News

Parker Institute For Cancer Immunotherapy, Bristol-Myers Squibb And The Cancer Research Institute Announce Collaboration To Accelerate Immuno-Oncology Research

Parker Institute For Cancer Immunotherapy, Bristol-Myers Squibb And The Cancer Research Institute Announce Collaboration To Accelerate Immuno-Oncology Research

The Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb Company (NYSE: BMY) and the Cancer Research Institute (CRI) today announced a multi-year clinical research collaboration to coordinate and rapidly...

Trump, Ryan Spike Health Care Vote in Setback for President, GOP

Trump, Ryan Spike Health Care Vote in Setback for President, GOP

The vote on repealing and replacing Obamacare has been pulled from the House floor.

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) For The Treatment Of Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-based Therapy

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) For The Treatment Of Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-based Therapy

Bristol-Myers Squibb Company (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo as monotherapy for the treatment of squamous cell cancer of the...

Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment

Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment

Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.

After Snap IPO, SEC Nominee Sees Change in Power Balance

After Snap IPO, SEC Nominee Sees Change in Power Balance

The White House nominee acknowledged meeting with Carl Icahn after he was nominated - but all they talked about was the billionaire insurgent's view on the importance of activist investors.

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks Lower as Crude Slump Weighs on Energy Sector

Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference

Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.

Biotech Premarket Movers: CytomX, Aevi, Esperion

Biotech Premarket Movers: CytomX, Aevi, Esperion

CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.

CytomX Soars on Bristol-Myers Partnership

CytomX Soars on Bristol-Myers Partnership

Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock Futures Slip After G20 Meeting Raises Fears of Protectionism

Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details

European stocks drifted lower Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade

European stocks are expected to open mixed Monday following a holiday-thinned trading session in Asia as investors prepare for key inflation and private sector activity data later in the week.

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Dow, S&P 500 Decline as Health Care Losses Counter Gains

Wall Street ends a jampacked week little changed as a selloff in health care stocks counters broad gains elsewhere.

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report

Fired former U.S. Attorney Preet Bharara was investigating stock trades made by Health and Human Services Secretary Tom Price, according to one report.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Allergan, Schlumberger, Caterpillar: Doug Kass' Views

Doug Kass shares his thoughts on Allergan, and says that Caterpillar remains purr-fect for shorting.

Bristol-Myers Squibb To Announce Results For First Quarter 2017 On April 27

Bristol-Myers Squibb To Announce Results For First Quarter 2017 On April 27

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2017 on Thursday, April 27, 2017.

Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)

Don't Give the Fed Credit for This Bull: Cramer's 'Mad Money' Recap (Thursday 3/9/17)

Big market gains were the result of great companies, CEOs and the people behind them -- not just the Fed, says Jim Cramer.

Cramer: Don't Give the Fed Credit

Cramer: Don't Give the Fed Credit

Most of the 10 best stocks of the bull market did it their way.

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President And Chief Scientific Officer

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President And Chief Scientific Officer

Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has appointed Dr.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders at Bristol-Myers Squibb, SunOpta and three other companies have been scooping up shares of their own stock lately.

Bristol-Myers Squibb To Take Part In Barclays Global Health Care Conference

Bristol-Myers Squibb To Take Part In Barclays Global Health Care Conference

Bristol-Myers Squibb Company (NYSE:BMY) will present at Barclays Global Health Care Conference on Wednesday, March 15, 2017, in Miami.

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

What You Should Know About OncoSec's IL-12 Melanoma Immunotherapy

In a 24-week trial of 22 patients, OncoSec saw a 41% response rate